Founder

Twenty years building pharma commercial analytics from the inside. Now building the agents to run it.

BS
Founder & CEO
sukhin@b-synth.net
Pharma Commercial GTN & 340B Patient Funnel AI/ML at Scale Managed Care Data Science

Baseline Synthetic's founder built and led the analytics functions that govern how a top-five US pharmaceutical company commercializes its products — how patients are tracked through treatment, how channel and payer performance is measured, and how billions of dollars in revenue are recognized and optimized. The structural efficiency that defined that work is the model for what Baseline Synthetic delivers at industry scale.

50%+ cost reduction in a global analytics reorganization, with quality improvement
VP-level data science leader incubating commercial AI capabilities at industry scale
20 years across consulting and industry — ZS Associates and a top-five US pharma company

As Vice President of Data Science, he led the global commercial data science function incubating the company's next generation of AI/ML capabilities — analytics chatbots spanning primary and secondary data, agent-driven patient funnel diagnostics, and AI-powered alert systems built on detailed claims data. As Senior Director of Commercial Analytics, he led the reorganization of the global analytics services function, delivering more than 50% cost savings while improving analytical quality and insourcing high-value innovation.

Baseline Synthetic is built on a precise observation: the AI capabilities that now exist are sufficient to perform the analytical work the founder has led across two decades. The bottleneck has never been model capability — it has been the domain expertise and data architecture required to deploy AI correctly in a domain with this much regulatory complexity, data fragility, and financial consequence. That bottleneck is what Baseline Synthetic removes.

Career

Senior commercial leader, top-five US pharmaceutical company
Operations Lead, multi-billion-dollar franchise
2024 – Present
Commercial operations lead for one of the company's highest-priority US franchises. Owns planning, performance management, insights generation, and commercial targeting strategy — reporting directly to the franchise head.
Senior commercial leader, top-five US pharmaceutical company
Customer Effectiveness Lead, Customer Engagement Platform
2022 – 2024
Led strategic field force planning, omnichannel deployment, and targeting operations for the enterprise Customer Engagement Platform — translating complex commercial intent into field execution at scale.
Senior commercial leader, top-five US pharmaceutical company
Vice President, Data Science
2021 – 2022
Built and led the global commercial data science function — incubating analytics chatbots spanning primary and secondary data, agent-driven patient funnel diagnostics, and AI-powered alert systems on detailed claims data. The earliest production incarnation of what Baseline Synthetic now delivers as a product.
Senior commercial leader, top-five US pharmaceutical company
Senior Director, Commercial Analytics
2017 – 2021
Led the global commercial analytics Center of Excellence. Managed a reorganization that delivered 50%+ cost savings while improving analytical quality and insourcing innovation. Owned global demand forecasting and revenue risk visibility for executive leadership.
Senior commercial leader, top-five US pharmaceutical company
Director, Data Science
2016 – 2017
Applied advanced analytics and big-data methods to commercial problems including digital channel effectiveness, field engagement optimization, and emerging market attractiveness modeling.
Senior commercial leader, top-five US pharmaceutical company
Senior Manager / Team Lead, Commercial Decision Analytics
2012 – 2016
Translated analytical outputs into commercial guidance for senior leadership. Selected for an 18-month regional assignment in Shanghai; led the China Commercial Decision Analytics team through a major field force restructuring.
Eisai Inc
Senior Manager, Management Science
2011 – 2012
Led analytical initiatives across primary care and oncology portfolios. Architected the Closed Loop Marketing capabilities roadmap across sales, marketing, and business technology.
ZS Associates
Analytics & Strategy Consultant
2004 – 2011
Seven years serving pharmaceutical commercial clients across organization design, managed care analytics, incentive plan design, segmentation and targeting, commercial assessment, and business development strategy. The foundation for two decades of pharma commercial domain depth.

Education

MS, Operations Research
University of Wisconsin, Madison
2004
BE, Engineering
University of Madras, India
2001

Why now. Why this.

The convergence of model capability, agent frameworks, and cloud-scale data infrastructure that is transforming knowledge work broadly is — with the right domain expertise built in — sufficient to run the majority of pharma commercial analytics and operations functions autonomously. The bottleneck has never been the AI. It has been the expertise required to deploy it correctly in a domain with this much regulatory complexity, data fragility, and financial consequence.

The advantage of starting from inside the function is twofold: the semantic data model gets designed by someone who understands the business meaning of every field, not just its structure; and the model gets maintained at the velocity the business actually changes — not on a quarterly software release cycle. That is the velocity an entrenched data vendor cannot match.

See what we're building →